HLA-DP in rheumatoid arthritis

Area of Science:

• Immunogenetics
• Rheumatology
• Human Leukocyte Antigen (HLA) research

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease with complex genetic underpinnings.
• Human Leukocyte Antigen (HLA) genes are known to influence susceptibility to autoimmune diseases, including RA.
• Previous studies have identified associations between specific HLA-DR alleles and RA risk.

Purpose of the Study:

• To compare the frequencies of HLA-DR, HLA-Dw, and HLA-DPw specificities in patients with rheumatoid arthritis (RA) and Felty's syndrome (FS) compared to healthy controls.
• To investigate the potential protective or susceptibility roles of different HLA alleles in RA pathogenesis.
• To explore the interplay between HLA-DR and HLA-DP alleles in the context of RA and FS.

Main Methods:

• Case-control study comparing HLA allele frequencies.
• Utilized cellular typing for HLA-Dw and HLA-DPw specificities.
• Analyzed frequencies of HLA-DR4, HLA-Dw14, HLA-DPw1, and HLA-DPw3 in RA patients, FS patients, and normal controls.
• Calculated relative risks (RR) and P-values to assess statistical significance.

Main Results:

• Confirmed increased frequency of HLA-DR4 in RA patients (RR=3.98, P<0.001).
• Significantly increased frequency of HLA-Dw14 in RA patients (RR=11.90, P<0.001), particularly in DR4-positive RA patients.
• Identified a negative association with HLA-DPw3 (RR=0.51, P<0.05) and a tendential decrease in HLA-DPw1 in RA patients.
• Observed a marked decrease of HLA-DPw1 in FS patients, while HLA-DPw3 frequency was unaltered compared to DR4+ normals.

Conclusions:

• HLA-DR4 and HLA-Dw14 are confirmed susceptibility factors for rheumatoid arthritis.
• HLA-DPw1 may confer a protective effect in the presence of the major DR4-associated susceptibility gene(s) for RA.
• HLA-DPw3 demonstrates significant protective activity in the absence of DR4, suggesting a complex interaction between HLA alleles in RA pathogenesis.